UK Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Biotechnology
Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Insights
Autolus Therapeutics PLC (AUTL) reports significant progress with FDA approval of AUCATZYL, robust financial positioning, and strategic challenges in its Q3 2024 earnings call. Nov 13, 2024
GuruFocus News Interactive Media
Genius Sports Ltd (GENI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance
Genius Sports Ltd (GENI) reports impressive financial performance with significant revenue and EBITDA growth, raising its 2024 guidance amidst strategic expansions. Nov 13, 2024
GuruFocus News Biotechnology
Roivant Sciences Ltd (ROIV) Q2 2024 Earnings Call Highlights: Strong Cash Position and Strategic Initiatives Amidst Competitive Challenges
Roivant Sciences Ltd (ROIV) showcases robust financial health with $5.4 billion in cash and no debt, while navigating competitive pressures and strategic opportunities. Nov 13, 2024
GuruFocus News Travel & Leisure
International Game Technology PLC (IGT) Q3 2024 Earnings Call Highlights: Strong Profit Margins Amid Global Sales Challenges
IGT reports robust EBITDA and strategic growth in Italy, while navigating a decline in global same-store sales and restructuring impacts. Nov 13, 2024